UY39758A - Formulación de sotorasib - Google Patents

Formulación de sotorasib

Info

Publication number
UY39758A
UY39758A UY0001039758A UY39758A UY39758A UY 39758 A UY39758 A UY 39758A UY 0001039758 A UY0001039758 A UY 0001039758A UY 39758 A UY39758 A UY 39758A UY 39758 A UY39758 A UY 39758A
Authority
UY
Uruguay
Prior art keywords
sotorasib
formulation
disintegrant
diluent
lubricant
Prior art date
Application number
UY0001039758A
Other languages
English (en)
Inventor
E Houk Brett
Antonio Alvarez-Nunez Fernando
Jiemin Bao
Prasanth CHAMARTHY Sai
Paul Daurio Dominick
Naga Duggirala
Kiang Yuan-Hon
Angela Olsofsky
Namita Sawant
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of UY39758A publication Critical patent/UY39758A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<p>La divulgación proporciona formulaciones que comprenden sotorasib (1), un diluyente, un disgregante y un lubricante. (1)</p>
UY0001039758A 2021-05-06 2022-05-06 Formulación de sotorasib UY39758A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163184941P 2021-05-06 2021-05-06
US202163212316P 2021-06-18 2021-06-18

Publications (1)

Publication Number Publication Date
UY39758A true UY39758A (es) 2022-11-30

Family

ID=81748639

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039758A UY39758A (es) 2021-05-06 2022-05-06 Formulación de sotorasib

Country Status (15)

Country Link
US (1) US20240226020A1 (es)
EP (1) EP4333813A1 (es)
JP (1) JP2024516441A (es)
KR (1) KR20240004589A (es)
AU (1) AU2022270124A1 (es)
BR (1) BR112023023128A2 (es)
CA (1) CA3218087A1 (es)
CL (1) CL2023003289A1 (es)
CO (1) CO2023015033A2 (es)
CR (1) CR20230526A (es)
IL (1) IL307849A (es)
MX (1) MX2023012930A (es)
TW (1) TW202308640A (es)
UY (1) UY39758A (es)
WO (1) WO2022235904A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3738593A1 (en) * 2019-05-14 2020-11-18 Amgen, Inc Dosing of kras inhibitor for treatment of cancers

Also Published As

Publication number Publication date
CR20230526A (es) 2024-01-08
KR20240004589A (ko) 2024-01-11
TW202308640A (zh) 2023-03-01
US20240226020A1 (en) 2024-07-11
MX2023012930A (es) 2023-11-13
CA3218087A1 (en) 2022-11-10
JP2024516441A (ja) 2024-04-15
IL307849A (en) 2023-12-01
CL2023003289A1 (es) 2024-04-12
BR112023023128A2 (pt) 2024-01-30
CO2023015033A2 (es) 2023-11-20
WO2022235904A1 (en) 2022-11-10
AU2022270124A1 (en) 2023-11-02
EP4333813A1 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
CL2021002880S1 (es) Estuche de auriculares. (divisional solicitud 202000595)
UY32116A (es) Una formulación sólida de dosificación farmacéutica
BRPI0412684A (pt) compostos ppar-ativos
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
ATE415166T1 (de) Antivirale pharmazeutische zusammensetzungen
DE602008004356D1 (de) Konservierungsmittelfreie augenlösung auf prostaglandin-basis
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
DOP2013000023A (es) Un compuesto seleccionado del acido 6-(4-bromo-2-cloro-fenilamino) -7-fluror-3-metil-3h-benzoimidazol -5-carboxilico (2-hidroxi-etoxi)-amida y sales farmaceuticamente aceptables del mismo, y composiciones farmaceuticas que contienen dicho compuesto
BR112012028048A2 (pt) ferramenta de corte, e, saída de refrigerante da ferramenta de corte
CL2021001956A1 (es) Formulaciones de inmunoconjugado anti-cd79b estables. (divisional solicitud 202002624)
JP2022102688A5 (es)
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
JPWO2021193234A5 (es)
CR8277A (es) Procedimiento para la sintesis de 6-amino- 4-[(3-cloro-4-fluorofenil)amino]-7-etoxiquinolin-3-carbonitrilo
MX2022013644A (es) Composicion que contiene aceite de fluor.
BR112023002923A2 (pt) Formulação farmacêutica que compreende um bite, anticorpo bespecífico, e metionina
UY39758A (es) Formulación de sotorasib
AR125801A1 (es) Formulación de sotorasib
BR112021021093A2 (pt) Graxas lubrificantes compreendendo sabões de metais e sabões de complexos de metais à base de ácido r-10-hidroxioctadecanóico
UY27514A1 (es) Compuestos basicos lineales que tienen actividad antagonista de nk-2 y sus formulaciones.
SV2003001179A (es) Formulacion de 2-metilo-tieno-benzodiacepina liofilizada ref. x-11102
IS8202A (is) Deramsíklan-fúmarattöflur
BR112024002022A2 (pt) Aprimoramentos de sinalização para multiplexação simultânea em uma rede de acesso e backhaul integrados
FR3087089B1 (fr) Composition desinfectante a usage topique
CL2020000620S1 (es) Cabezal de cepillo de dientes. (divisional solicitud 201900808)